Healthcare Training 2021 - HIPAA and SAMHSA 42 CFR Part 2: Rules for Managing Disclosure of Substance Use Disorder Information

Overview:
For much of healthcare, HIPAA sets the standards for how to manage uses and disclosures of patient information, known as Protected Health Information (PHI).
But when it comes to information related to the treatment of substance use disorders, regulations of the Substance Abuse and Mental Health Services Administration (SAMHSA) under 42 CFR Part 2 prevail. These rules apply to information collected under SAMHSA, which may be difficult to separate from "regular" PHI in your records, and there are special rules for disclosure and re-disclosure of substance abuse treatment information.
Attendees will learn how the rules on Substance Use Disorder information can affect records storage and release processes, and how the HIPAA and SAMHSA rules are different and similar. There are some significant differences between the HIPAA and 42 CFR Part 2 rules that need to be understood, especially when it comes to involving family and friends in an individual's treatment, which HIPAA allows, but Part 2 does not.